Brief: Cingulate reports Q2 results
11/08/2022 11:49
Aug 11 (Reuters) - Cingulate Inc CING.O :
* . REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS AND
PROVIDES
CLINICAL AND BUSINESS UPDATE
* AS OF JUNE 30, 2022, CINGULATE HAD $8.2 MILLION IN CASH
AND CASH
EQUIVALENTS
* QTRLY NET LOSS PER SHARE BASIC AND DILUTED $0.36
Source text for Eikon: ID:nGNX9PMBmT
Further company coverage: CING.O
Recent news on VectivBio Holding AG
See all newsBrief: Ironwood And VectivBio Announce Expiration Of Hart-Scott-Rodino Waiting Period For Proposed Acquisition Of VectivBio
Brief: Ironwood Pharmaceuticals Says If Deal Aborts, VectivBio To Pay Termination Fee
U.S. STOCKS ON THE MOVE-Pfizer, Zoom Video, American Airlines
U.S. STOCKS ON THE MOVE-Atea Pharma, Microbot Medical, Krystal
U.S. STOCKS ON THE MOVE-NuScale Power Corp, Foot Locker, Greenhill